Evolutionary Genomics, Inc. (FNAM) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
4220 MORNINGSTAR DRIVE CASTLE ROCK, CO 80108 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8731 - Commercial Physical and Biological Research (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 214 | 216 | 87 | 160 | 1,171 | 2,122 | |||
| Cash and cash equivalents | 214 | 216 | 45 | 131 | 880 | 2,058 | |||
| Short-term investments | 42 | 28 | 291 | 64 | |||||
| Receivables | 7 | 40 | 9 | ||||||
| Prepaid expense | 42 | 62 | 24 | 23 | 22 | 22 | |||
| Other undisclosed current assets | |||||||||
| Total current assets: | 256 | 278 | 118 | 223 | 1,193 | 2,154 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 19 | 51 | 89 | 127 | 165 | 206 | |||
| Intangible assets, net (including goodwill) | 2,658 | 3,664 | 4,036 | 4,038 | 4,041 | 4,043 | |||
| Intangible assets, net (excluding goodwill) | 2,658 | 3,664 | 4,036 | 4,038 | 4,041 | 4,043 | |||
| Total noncurrent assets: | 2,676 | 3,715 | 4,124 | 4,165 | 4,206 | 4,249 | |||
| TOTAL ASSETS: | 2,932 | 3,993 | 4,243 | 4,389 | 5,399 | 6,403 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 19 | 3 | 19 | 11 | 46 | ||||
| Interest and dividends payable | ✕ | 1,523 | 1,236 | ||||||
| Accrued liabilities | |||||||||
| Other undisclosed accounts payable and accrued liabilities | (1,504) | (1,233) | 19 | 11 | 46 | ||||
| Total current liabilities: | 19 | 3 | 19 | 11 | 46 | ||||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 3,744 | 2,246 | |||||||
| Long-term debt, excluding current maturities | 3,744 | 2,246 | |||||||
| Liabilities, other than long-term debt | 987 | 955 | 955 | 1,486 | |||||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | 955 | 955 | 1,486 | ||
| Deferred income tax liabilities | 987 | ✕ | ✕ | ✕ | |||||
| Total noncurrent liabilities: | 3,744 | 2,246 | 987 | 955 | 955 | 1,486 | |||
| Total liabilities: | 3,763 | 2,249 | 1,007 | 955 | 966 | 1,532 | |||
| Temporary equity, carrying amount | 3,570 | 3,570 | 3,570 | 3,030 | 3,030 | 3,030 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (4,400) | (1,826) | (334) | 404 | 1,404 | 1,841 | |||
| Preferred stock | 1,522 | 1,236 | 951 | 197 | |||||
| Common stock | 6 | 6 | 6 | 6 | 6 | 6 | |||
| Additional paid in capital | 11,950 | 12,016 | 12,081 | 12,295 | 12,439 | 12,579 | |||
| Accumulated deficit | (17,877) | (15,084) | (13,372) | (12,579) | (11,480) | (10,940) | |||
| Other undisclosed equity, attributable to parent | 681 | 439 | |||||||
| Total equity: | (4,400) | (1,826) | (334) | 404 | 1,404 | 1,841 | |||
| TOTAL LIABILITIES AND EQUITY: | 2,932 | 3,993 | 4,243 | 4,389 | 5,399 | 6,403 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 13 | 123 | 115 | 33 | 222 | |||
| Gross profit: | 13 | 123 | 115 | 33 | 222 | |||
| Operating expenses | (2,878) | (2,892) | (898) | (952) | (1,335) | (1,275) | ||
| Operating loss: | (2,878) | (2,880) | (775) | (837) | (1,303) | (1,053) | ||
| Nonoperating income (expense) | 84 | 181 | 14 | (262) | 233 | (99) | ||
| Investment income, nonoperating | 1 | 0 | 0 | 1 | 233 | (99) | ||
| Interest and debt expense | 74 | |||||||
| Loss from continuing operations before equity method investments, income taxes: | (2,794) | (2,625) | (761) | (1,099) | (1,070) | (1,152) | ||
| Other undisclosed loss from continuing operations before income taxes | (74) | |||||||
| Loss from continuing operations before income taxes: | (2,794) | (2,699) | (761) | (1,099) | (1,070) | (1,152) | ||
| Income tax expense (benefit) | 987 | (32) | 530 | |||||
| Loss from continuing operations: | (2,794) | (1,712) | (793) | (1,099) | (540) | (1,152) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (2,794) | (1,712) | (793) | (1,099) | (540) | (1,152) | |
| Net loss attributable to parent: | (2,794) | (1,712) | (793) | (1,099) | (540) | (1,152) | ||
| Preferred stock dividends and other adjustments | (286) | (286) | (269) | (242) | (242) | (197) | ||
| Net loss available to common stockholders, diluted: | (3,080) | (1,997) | (1,063) | (1,341) | (782) | (1,349) | ||
Comprehensive Income ($ in thousands)
| 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (2,794) | (1,712) | (793) | (1,099) | (540) | (1,152) | ||
| Other comprehensive loss | (15) | |||||||
| Comprehensive loss, net of tax, attributable to parent: | (2,809) | (1,712) | (793) | (1,099) | (540) | (1,152) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.